Treating buccinator with botulinum toxin in patients with facial synkinesis: A previously overlooked target

Ophthalmic Plastic and Reconstructive Surgery

Volumn 32, Issue 2, 2016, Pages 138-141

  Wei, Leslie A ^a   Diels, Jacqueline ^b   Lucarelli, Mark J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ACETYLCHOLINE RELEASE INHIBITOR;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BELL PALSY; BUCCINATOR MUSCLE; CHEEK; CHOLESTEATOMA; CLINICAL ARTICLE; DRUG INDICATION; EYELID CLOSURE; FACE MUSCLE; FACIAL EXPRESSION; FACIAL NERVE INJURY; FACIAL NERVE PARALYSIS; FACIAL SYNKINESIS; FEMALE; HUMAN; HYPERKINESIA; MALE; MASTICATION; MEDICAL RECORD REVIEW; MUSCLE HYPERTONIA; MUSCLE SPASM; MUSCLE TRAINING; NEUROMUSCULAR RETRAINING; OUTCOME ASSESSMENT; PAROTID GLAND TUMOR; PATIENT SATISFACTION; POSTERIOR FOSSA; PRIORITY JOURNAL; QUESTIONNAIRE; REST; RETROSPECTIVE STUDY; SYNKINESIS; SYNKINESIS ASSESSMENT QUESTIONNAIRE; UNITED STATES; DRUG EFFECTS; FACIAL PARALYSIS; FOLLOW UP; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY;

ACETYLCHOLINE RELEASE INHIBITORS; ADOLESCENT; ADULT; AGED; BOTULINUM TOXINS, TYPE A; FACIAL MUSCLES; FACIAL PARALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PATIENT SATISFACTION; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; SYNKINESIS;

EID: 84944339489     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0000000000000449     Document Type: Article

References (22)

1. Fu L, Bundy C, Sadiq SA. Psychological distress in people with disfigurement from facial palsy. Eye (Lond) 2011;25:1322-6.
2. Couch SM, Chundury RV, Holds JB. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthal Plast Reconstr Surg 2014;30:246-50.
3. Navarrete Alvaro ML, Junyent J, Torrent L. [Botulinum toxin and facial palsy. Our experience]. Acta Otorrinolaringol Esp 2010;61:277-81.
4. Choi KH, Rho SH, Lee JM, et al. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthet Surg 2013;66:1058-63.
5. Chua CN, Quhill F, Jones E, et al. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit 2004;23:213-8.
6. Laskawi R, Damenz W, Roggenkamper P, Baetz A. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol 1994;Dec:S195-9.
7. Remigio A, Salles A, Faria J, Ferreira M. Comparison of the efficacy of the 1: 3 onabotulinumtoxinA: abobotulinumtoxinA ratio for the treatment of asymmetry after long-term facial paralysis. Plast Reconstr Surg 2015;135:239-49.
8. Toffola ED, Furini F, Redaelli C, et al. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 2010;32:1414-8.
9. Balliet R, Shinn JB, Bach-y-Rita P. Facial paralysis rehabilitation: retraining selective muscle control. Int Rehabil Med 1982;4:67-74.
10. Ross B, Nedzelski JM, McLean JA. Efficacy of feedback training in long-standing facial nerve paresis. Laryngoscope 1991;101(7 pt 1):744-50.
11. Lindsay RW, Robinson M, Hadlock TA. Comprehensive facial rehabilitation improves function in people with facial paralysis: a 5-year experience at the Massachusetts Eye and Ear Infirmary. Phys Ther 2010;90:391-7.
12. Hohman MH, Lee LN, Hadlock TA. Two-step highly selective neurectomy for refractory periocular synkinesis. Laryngoscope 2013;123:1385-8.
13. Guerrissi JO. Selective myectomy for postparetic facial synkinesis. Plast Reconstr Surg 1991;87:459-66.
14. Mehta RP, Hadlock TA. Botulinum toxin and quality of life in patients with facial paralysis. Arch Facial Plast Surg 2008;10:84-7.
15. Micheli F, Scorticati MC, Raina G. Beneficial effects of botulinum toxin type a for patients with painful tic convulsif. Clin Neuropharmacol 2002;25:260-2.
16. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996;114:380-6.
17. Mehta RP, WernickRobinson M, Hadlock TA. Validation of the Synkinesis Assessment Questionnaire. Laryngoscope 2007;117:923-6.
18. McElhinny ER, Reich I, Burt B, et al. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A. Ophthal Plast Reconstr Surg 2013;29:175-8.
19. Roggenkämper P, Laskawi R, Damenz W, et al. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol 1994;86:395-402.
20. Dall'Angelo A, Mandrini S, Sala V, et al. Platysma synkinesis in facial palsy and botulinum toxin type A. Laryngoscope 2014;124:2513-7.
21. Rogers CR, Schmidt KL, VanSwearingen JM, et al. Automated facial image analysis: detecting improvement in abnormal facial movement after treatment with botulinum toxin A. Ann Plast Surg 2007;58:39-47.
22. Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope 1996;106(12 pt 1):1491-6.